<DOC>
	<DOC>NCT00180960</DOC>
	<brief_summary>The purpose of this study is to evaluate the treatment of a cancerous disease of the peritoneum with complete cytoreductive surgery with intraperitoneal chemohyperthermia using oxaliplatin plus irinotecan. This is a Phase II study with 100 patients. Origins of the tumors: these include colon, rectum, appendix, peritoneum, and endocrine tumors.</brief_summary>
	<brief_title>Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Endocrine Gland Neoplasms</mesh_term>
	<mesh_term>Appendiceal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>Peritoneal seedings coming from colon, rectum, pseudomyxoma (appendix), peritoneum (mesothelioma and serous tumors), or endocrine tumors. No extraabdominal metastases Good general status (American Society of Anesthesiologists Physical Status score [ASA] 1 or 2) Signed consent Tumor seedings coming from other origins Huge peritoneal carcinomatosis (peritoneal score &gt; 25, except for pseudomyxomas) Peritoneal carcinomatosis progressing rapidly Presence of extraabdominal metastases Patients presenting contraindications to the use of oxaliplatin or irinotecan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>